Countries are now challenged by the rapid development of vaccines aimined at the primary
prevention of infections. In the years to come, several vaccines will need to be considered as …

A common sexually transmitted infection, human papillomavirus (HPV) has been linked to
the development of cervical, anogenital, and head and neck cancers and genital warts.(2) …

Cervical cancer is the second most common form of cancer among women, and responsible
for 274,000 deaths each year, most of which occur in developing countries. Persistent …

Worldwide, cervical cancer is the second most common cancer of women. Less-developed
countries bear the greatest burden in terms of morbidity and mortality, largely due to the lack …

With the approval of Gardasil®(Merck and Co., Inc., Whitehouse Station, NJ) in June of 2006
and the pending approval of Cervarix®(GlaxoSmithKline, London, UK), two prophylactic …

The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …

Cervical cancer, the most common cancer affecting women in developing countries, is
caused by persistent infection with" high-risk" genotypes of human papillomaviruses (HPV) …

The last 20 years is one of the most remarkable periods in the fight against cancer, with the
realization that some human papillomaviruses are causally related to cancer and with the …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Vaccines against HPV infections have the potential to be a more practical and cost–effective
way to reduce the incidence of cervical cancer. Two candidate HPV vaccines, both …